Five-Month Observation of Persistent Diabetic Macular Edema after Intravitreal Injection of Ozurdex Implant
Aims. This retrospective analysis was aimed at evaluating the effectiveness of treatment of persistent diabetic macular edema with intravitreal injections of 0.7 mg dexamethasone implant Ozurdex. The study comprised three male patien...
Saved in:
Main Authors: | Dominik Zalewski, Dorota Raczyńska, Krystyna Raczyńska |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2014-01-01
|
Series: | Mediators of Inflammation |
Online Access: | http://dx.doi.org/10.1155/2014/364143 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Macular Oedema Related to Idiopathic Macular Telangiectasia Type 1 Treated with Dexamethasone Intravitreal Implant (Ozurdex)
by: Mohamed Loutfi, et al.
Published: (2014-01-01) -
A New Side Effect of Intravitreal Dexamethasone Implant (Ozurdex®)
by: Erdem Eris, et al.
Published: (2017-01-01) -
Clinical Observation of Phacoemulsification Combined with Intravitreal Injection of Conbercept in Cataract Patients with Diabetic Macular Edema
by: Jing Wang, et al.
Published: (2021-01-01) -
Splitting of a Dexamethasone Implant (Ozurdex) following the Injection
by: Oya Donmez, et al.
Published: (2013-01-01) -
Suprachoroidal Versus Intravitreal Injection of Triamcinolone Acetonide As Primary Treatment For Diabetic Macular Edema
by: Fatima Shafqat Khan, et al.
Published: (2023-12-01)